Centre sets new standards for pharma firms after overseas deaths
Image Credit: newsbytes
The Central government has issued new manufacturing standards for pharmaceutical companies in India, an official notification said, per Reuters. The decision comes after several overseas deaths since 2022 were linked to Indian-made drugs. This is also aimed at increasing scrutiny of the pharma sector and enhancing the 3.2 lakh crore industry's reputation. Large drug makers have six months to address these concerns, while smaller manufacturers have 12 months. The latter requested more time due to their debt burden.